Inspyr Therapeutics, Inc., formerly GenSpera, Inc., is an integrated biopharmaceutical company. The Company is focused on the development of therapies to treat cancer, inflammation, and other diseases. It operates a technology platform based on adenosine chemistry and biology. Its product pipeline includes Mipsagargin; A2A antagonist; A2B antagonist; A2A agonist, and A2A/A2B Dual Antagonist. The Company is developing Mipsagargin for different tumor types, including Hepatocellular carcinoma (liver cancer), Glioblastoma (brain cancer) and Prostate cancer. The other combinations of Mipsagargin include PD1/PDL1 combination and Xenograft models. The A2A antagonist; A2B antagonist; A2A agonist, and A2A/A2B dual antagonist are its adenosine receptor programs.
San Antonio, Texas, United States
We're covering technologies for this company as we speak. We will have an update soon
Find rich insights on prospects from Inspyr Therapeutics Inc including contact information, interests,skills and more
We don't have enough content for Inspyr Therapeutics Inc employees.
Find recent and open job postings from Inspyr Therapeutics Inc
We don't have enough content for Inspyr Therapeutics Inc jobs.
Get news, alerts, and updates about Inspyr Therapeutics Inc
We don't have enough content for Inspyr Therapeutics Inc company news and alerts.
The official website of Inspyr Therapeutics Inc is http://www.inspyrtx.com/.
The phone number for Inspyr Therapeutics Inc is 210.479.8112.
Slintel keeps track of 1-10 employees who are working at Inspyr Therapeutics Inc.
Inspyr Therapeutics Inc is in the industry of Pharmaceuticals.
Inspyr Therapeutics Inc headquarters are at San Antonio, Texas, United States.